Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Patrys.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021
Health & Biotech
ASX Health Stocks: AFT Pharma jumps 13pc on FDA submission, Imugene up 10pc on CAR-T progress
Health & Biotech
ASX Health Stocks: Proteomics jumps 13pc on diabetes test
Health & Biotech
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing
News
Closing Bell: ASX dragged down by delta, energy stocks
Health & Biotech
ASX health stocks: Mayne Pharma slapped with lawsuit, Patrys encounters clinical trial delays
News
10 at 10: These ASX stocks are in the market’s spotlight this morning
Health & Biotech
ASX health stocks: 4D Medical leads after ramping up its game in the US
Stockhead TV
V-Con: Talking medical innovations and breakthrough treatments with ASX biotechs
Health & Biotech
Check Up: From Moderna’s effective jabs to Patrys’ brain cancer breakthrough
News
Weekly ASX small cap wrap: Who’s taking over the skies?
Health & Biotech
As neuroscience blurs the line between tech and biology, these ASX brain health stocks are on the frontline
News
Quarterlies Top 5: Here’s another online market place that’s rising today
Health & Biotech
Chimeric IPO: What ASX stockspert Bhavdip143 likes so much about the $35m CAR T play
News
Rise and Shine: What you need to know before the ASX opens
News
